Publications by authors named "D H Reyes"
PSMA-PET/CT has emerged as a superior diagnostic tool for prostate cancer, demonstrating enhanced accuracy over conventional imaging methods. Although sensitive for detecting local and metastatic prostate tumors, it can also identify other non-prostate PSMA positive lesions. Here, we report a rare case of a 67-year-old patient with metastatic prostate adenocarcinoma who was found to have an incidental Gastrointestinal Stromal Tumor (GIST), during restaging with 68Ga-PSMA-11 PET/CT.
View Article and Find Full Text PDFWe aimed to evaluate the effects of prepartum supplementation of different I sources (Ascophyllum nodosum [ASCO] meal and ethylenediamine dihydroiodide [EDDI]) on colostrum yield of cows, and blood concentrations of glucose, BHB, and thyroid hormones and growth of dairy calves. Forty multiparous Holstein cows were blocked by lactation number and expected calving date and assigned to 1 of 4 treatments 28 d before parturition: (1) EDDI supplemented (11 mg/d) to a basal diet to meet the NRC (2001) I concentration of 0.5 mg of I/kg of DMI (control = CON [0 g/d of ASCO meal]; actual I concentration = 0.
View Article and Find Full Text PDFAim: To explore nurse ability to recognize emotion and its association with clinical empathy.
Background: Empathy is elemental to nursing care and positively effects patient and nurse outcomes, yet self-reported clinical empathy has declined over the past decade. One hypothesized contributor to the ability of a nurse to be empathic is whether they can recognize emotion, a phenomenon thus far unstudied among nurses.
Article Synopsis
- The study focuses on evaluating the long-term outcomes and natural history of chronic subdural hematoma (cSDH) treatment using middle meningeal artery (MMA) embolization over a 12-month period.
- A retrospective analysis was conducted involving 49 patients who underwent MMA embolization, detailing patient demographics and various clinical outcomes, including symptom resolution and recurrence rates.
- Results indicated significant clinical improvement in patients within one month post-procedure, with many elderly patients (average age 73) experiencing previous trauma mainly due to falls.
Article Synopsis
- Pompe disease results from a deficiency in acid alpha-glucosidase, leading to muscle weakness, respiratory issues, and cardiomyopathy in infants; the only current treatment is enzyme replacement therapy (ERT).
- A new approach using a Centyrin protein-conjugated short interfering RNA (siRNA) targets the transferrin receptor (CD71) and the GYS1 enzyme to inhibit glycogen synthesis, potentially restoring glycogen balance instead of just degrading it.
- In tests on a Pompe mouse model, this novel siRNA conjugate effectively reduced GYS1 levels and glycogen accumulation, improving exercise performance, indicating its promise as a therapy for late-onset Pompe disease or in combination with ERT for infants.